Literature DB >> 27647283

Dopamine Receptor Genes Modulate Associative Memory in Old Age.

Goran Papenberg1,2, Nina Becker1,2,3, Beata Ferencz1,2, Moshe Naveh-Benjamin4, Erika J Laukka1,2, Lars Bäckman1,2, Yvonne Brehmer1,2,3.   

Abstract

Previous research shows that associative memory declines more than item memory in aging. Although the underlying mechanisms of this selective impairment remain poorly understood, animal and human data suggest that dopaminergic modulation may be particularly relevant for associative binding. We investigated the influence of dopamine (DA) receptor genes on item and associative memory in a population-based sample of older adults (n = 525, aged 60 years), assessed with a face-scene item associative memory task. The effects of single-nucleotide polymorphisms of DA D1 (DRD1; rs4532), D2 (DRD2/ANKK1/Taq1A; rs1800497), and D3 (DRD3/Ser9Gly; rs6280) receptor genes were examined and combined into a single genetic score. Individuals carrying more beneficial alleles, presumably associated with higher DA receptor efficacy (DRD1 C allele; DRD2 A2 allele; DRD3 T allele), performed better on associative memory than persons with less beneficial genotypes. There were no effects of these genes on item memory or other cognitive measures, such as working memory, executive functioning, fluency, and perceptual speed, indicating a selective association between DA genes and associative memory. By contrast, genetic risk for Alzheimer disease (AD) was associated with worse item and associative memory, indicating adverse effects of APOE ε4 and a genetic risk score for AD (PICALM, BIN1, CLU) on episodic memory in general. Taken together, our results suggest that DA may be particularly important for associative memory, whereas AD-related genetic variations may influence overall episodic memory in older adults without dementia.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27647283     DOI: 10.1162/jocn_a_01048

Source DB:  PubMed          Journal:  J Cogn Neurosci        ISSN: 0898-929X            Impact factor:   3.225


  6 in total

1.  Genetic variants and cognitive functions in patients with brain tumors.

Authors:  Denise D Correa; Jaya Satagopan; Axel Martin; Erica Braun; Maria Kryza-Lacombe; Kenneth Cheung; Ajay Sharma; Sofia Dimitriadoy; Kelli O'Connell; Siok Leong; Sasan Karimi; John Lyo; Lisa M DeAngelis; Irene Orlow
Journal:  Neuro Oncol       Date:  2019-10-09       Impact factor: 12.300

2.  Genetic markers of dopaminergic transmission predict performance for older males but not females.

Authors:  Kathleen E Hupfeld; David E Vaillancourt; Rachael D Seidler
Journal:  Neurobiol Aging       Date:  2018-02-10       Impact factor: 4.673

3.  Becoming a balanced, proficient bilingual: Predictions from age of acquisition & genetic background.

Authors:  Kelly A Vaughn; Arturo E Hernandez
Journal:  J Neurolinguistics       Date:  2018-01-05       Impact factor: 1.710

Review 4.  The DRD2 Taq1A A1 Allele May Magnify the Risk of Alzheimer's in Aging African-Americans.

Authors:  Kenneth Blum; Rajendra D Badgaiyan; Georgia M Dunston; David Baron; Edward J Modestino; Thomas McLaughlin; Bruce Steinberg; Mark S Gold; Marjorie C Gondré-Lewis
Journal:  Mol Neurobiol       Date:  2017-09-30       Impact factor: 5.590

5.  From Polygenic Scores to Precision Medicine in Alzheimer's Disease: A Systematic Review.

Authors:  Judith R Harrison; Sumit Mistry; Natalie Muskett; Valentina Escott-Price
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

6.  Association of expression of DRD2 rs1800497 polymorphism with migraine risk in Han Chinese individuals.

Authors:  Yingfeng Deng; Jianping Huang; Huijun Zhang; Xueqin Zhu; Qin Gong
Journal:  J Pain Res       Date:  2018-04-12       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.